Arti is fulfilling a lifelong ambition with Novartis. Ever since she contracted malaria as a little girl, she has been driven to understand the mechanisms of human disease. Today, she is helping to deliver a new generation of breakthroughs as part of our neuroscience team – reimagining medicine for patients everywhere. Find out how you can pursue your purpose at https://lnkd.in/gpUjVhUT #ThriveTogether #NovartisCareers
Info
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki
- Website
-
http://www.novartis.com
Externer Link zu Novartis
- Branche
- Arzneimittelherstellung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Basel, Baselstadt
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand und Gene and cell therapy
Orte
Beschäftigte von Novartis
Updates
-
When everyone can take part, we all go further. As a proud partner of the Special Olympics World Winter Games Switzerland 2029, we’re making a four-year commitment to inclusion, supporting participation, dignity, and belonging in sport, in the workplace, and across society. Because inclusion isn’t symbolic, it’s something we build together. https://lnkd.in/gJZVM5-j #Inclusion #PoweringPotential
Inclusion is something we build together.
-
Novartis delivered strong growth in priority brands and recent launches during Q1 2026, while US generic erosion weighed on results as expected. We continued to advance our pipeline with innovation milestones, a completed acquisition and announced early-stage deals. With the momentum we are seeing across the business, we remain on track to deliver our full year guidance. Link to press release: https://lnkd.in/gCaPwCtQ #NVSQ126
-
At only 12 weeks old, Wonder was admitted to a hospital in Ghana with life-threatening malaria. Until recently, there were no medicines designed for babies his weight. Wonder was one of the first babies treated with a new antimalarial for newborns and young infants under 5kg. Soon, more babies like Wonder may be able to receive appropriate care, as the World Health Organization today has prequalified this product, taking another essential step toward enabling greater access across regions endemic with malaria in Africa. Find out more: https://lnkd.in/ggQMf9qm #WorldMalariaDay Medicines for Malaria Venture | Tedros Adhanom Ghebreyesus | Daniel Ngamije Madandi
-
Early conversations can positively shape an entire chronic myeloid leukemia (CML) journey. For Victoria, speaking openly with her doctor, Dr. Tim Hughes, made all the difference. Together, they share how creating space for questions early on supported true shared decision making, from clinical choices to everyday life. Watch the full conversation here: https://lnkd.in/gRd5AdPN #CML #ReimaginingMedicine
-
This Sjögren’s Awareness Month, we’re thrilled TV personality and Sjögren's advocate Carrie Ann Inaba is lending her voice to our new campaign, SJÖUT for Sjögren’s. Sjögren’s disease is a serious, systemic autoimmune disease that can affect the entire body with a wide spectrum of symptoms, including severe dryness, fatigue, pain, and an increased risk of lymphoma. Yet for many people living with it, their symptoms go overlooked, and their experiences are downplayed. Our campaign serves to raise awareness of this disease through Carrie Ann by sharing her experience of living with it for over a decade. Stay tuned for more and visit SjoutForSjogrens.com for resources and information about this disease
-
Sustainability and social impact underpin how Novartis drives long‑term performance, strengthening resilience, fuelling innovation and supporting healthcare systems for the future. We also know that progress happens fastest when we work together. That’s why this week, leaders from the life‑sciences community came together at the Novartis Pavillon around a shared conviction: tackling climate change demands collaboration. Thank you to our partners at Lonza, Roche,Syngenta and the Kanton Basel-Stadt. https://lnkd.in/gCJhbqhQ
-
-
For Maria, the fight against Chagas disease is personal. Her mother is one of the millions of people in Latin America who have been impacted by this life-changing parasitic infection. With Novartis, she is helping to tackle Chagas in a way that makes patients feel valued and seen. Whatever drives you to make an impact, find the opportunity at https://lnkd.in/gjcnNFxq #WorldChagasDay #NovartisCareers #ThriveTogether
-
The epidemic of chronic disease goes beyond breakthrough medicines, and so do we. From the U.S. to emerging economies, Novartis is expanding efforts to bring better care for cancer and heart disease to communities beyond the reach of health systems. Putting health in the hands of communities in 30+ countries by 2030, together with local partners. Find out more: https://lnkd.in/gRqyZ5uh
-
IgA nephropathy (IgAN) is a progressive kidney disease in which immune complexes deposit in the kidneys, triggering inflammation. Because early symptoms are often mild or absent, many people are diagnosed only after significant kidney damage has occurred. As the World Congress of Nephrology comes to a close today, conversations around kidney health underscore the importance of continued awareness, earlier recognition, and a deeper understanding of diseases like IgAN. Living with IgAN can affect daily life physically, emotionally, and socially as the disease progresses—highlighting why early diagnosis and appropriate care matter. Learn more: https://lnkd.in/gMA_iwsk #WCN2026 #ProtectingKidneys #TransformingCare #KidneyHealth #IgAN
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Novartis
Insgesamt 2 Finanzierungsrunden
Weitere Informationen auf Crunchbase
Letzte Runde
Fremdkapital nach Börsengang
Externer Crunchbase-Link für die letzte Finanzierungsrunde
2.487.694.394,00 $